Arca Biopharma said today it extended a US, Canadian and European clinical trial collaboration deal with medtech giant Medtronic (NYSE:MDT) for an additional year, now slated to continue until April 2019. Through the deal, Medtronic will support clinical trial use of its monitoring devices, collection of managed atrial fibrillation burden data and managed analysis of cardiac rhythms […]